Abstract

The present invention discloses pharmaceutical/nutritional compositions and methods for alleviating symptoms associated with perimenopausal and/or menopausal disorder or discomfort. The methods include the step of administering, to a subject in need thereof, an effective amount of a composition including at least 2% (w/w) phosphatidic acid, or salts thereof, out of the total effective composition, as a first effective ingredient for alleviating at least one discomfort symptom. Preferably, the composition further includes a suitable amount of at least one bio-available form of magnesium as a second effective ingredient. Preferably, at least one bio-available form is selected from the group consisting of: magnesium oxide, magnesium citrate, magnesium hydroxide, magnesium stearate, and a magnesium salt of the phosphatidic acid. Preferably, the step of administering is performed in a multi-part regimen, and is performed by at least one delivery method selected from the group consisting of: oral delivery and intravenous delivery.


Claims
Owners (US)
Download PDF
Document Preview
Document History
  • Publication: Feb 2, 2016
  • Application: Feb 26, 2015
    US US 201514632005 A
  • Priority: Feb 26, 2015
    US US 201514632005 A
  • Priority: Feb 22, 2013
    US US 201313773653 A
  • Priority: Oct 27, 2009
    US US 60697509 A

Download Citation


Sign in to the Lens

Feedback